X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (555) 555
index medicus (386) 386
gastroenteropancreatic neuroendocrine tumors (312) 312
gastroenteropancreatic tumors (275) 275
oncology (257) 257
male (239) 239
female (235) 235
neuroendocrine tumors (216) 216
middle aged (212) 212
adult (186) 186
aged (176) 176
endocrinology & metabolism (157) 157
radiology, nuclear medicine & medical imaging (157) 157
tumors (157) 157
management (151) 151
diagnosis (133) 133
carcinoid-tumors (130) 130
octreotide (128) 128
neuroendocrine tumors - pathology (127) 127
somatostatin receptor scintigraphy (124) 124
endocrine tumors (122) 122
gastroenterology & hepatology (121) 121
surgery (116) 116
somatostatin - analogs & derivatives (110) 110
pancreatic neoplasms - pathology (109) 109
cancer (106) 106
prognosis (106) 106
prognostic-factors (105) 105
neuroendocrine tumors - diagnosis (97) 97
somatostatin (95) 95
survival (94) 94
neuroendocrine tumors - drug therapy (90) 90
liver metastases (88) 88
metastasis (85) 85
treatment outcome (85) 85
medicine & public health (84) 84
aged, 80 and over (77) 77
interferon-alpha (76) 76
pancreas (75) 75
neuroendocrine tumors - therapy (72) 72
endocrine gastroenteropancreatic tumors (71) 71
neuroendocrine tumor (71) 71
neuroendocrine tumors - metabolism (71) 71
neuroendocrine tumors - diagnostic imaging (70) 70
carcinoid (68) 68
octreotide - therapeutic use (68) 68
chemotherapy (67) 67
zollinger-ellison-syndrome (64) 64
pancreatic neoplasms - diagnosis (63) 63
retrospective studies (63) 63
somatostatin - therapeutic use (63) 63
antineoplastic agents - therapeutic use (62) 62
enets consensus guidelines (62) 62
liver neoplasms - secondary (62) 62
phase-ii (61) 61
radionuclide imaging (61) 61
somatostatin analogs (61) 61
localization (60) 60
lanreotide (58) 58
therapy (58) 58
animals (57) 57
expression (57) 57
pancreatic neoplasms - drug therapy (56) 56
pancreatic neoplasms - diagnostic imaging (55) 55
receptors, somatostatin - metabolism (55) 55
neoplasm staging (54) 54
positron-emission-tomography (54) 54
epidemiology (53) 53
everolimus (53) 53
neoplasms (53) 53
pathology (52) 52
immunohistochemistry (51) 51
peptide receptor radionuclide therapy (51) 51
radionuclide therapy (51) 51
adolescent (50) 50
gastroenteropancreatic (49) 49
pancreatic neoplasms - metabolism (49) 49
research (48) 48
tomography, x-ray computed (48) 48
classification (47) 47
pancreatic neoplasms - therapy (47) 47
neuroendocrine tumors - mortality (46) 46
radiolabeled somatostatin analog (46) 46
sensitivity and specificity (46) 46
intestinal neoplasms - pathology (45) 45
neurosciences (45) 45
octreotide - analogs & derivatives (45) 45
pancreatic endocrine tumors (45) 45
phase-ii trial (45) 45
gastroenteropancreatic neuroendocrine tumor (44) 44
neuroendocrine tumours (44) 44
pharmacology & pharmacy (44) 44
care and treatment (43) 43
health aspects (43) 43
neuroendocrine tumors - genetics (43) 43
radiopharmaceuticals (43) 43
receptor radionuclide therapy (43) 43
neuroendocrine (42) 42
neuroendocrine tumors - radiotherapy (41) 41
pancreatic neoplasms - surgery (41) 41
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (883) 883
German (31) 31
French (28) 28
Spanish (17) 17
Polish (8) 8
Japanese (2) 2
Czech (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 11/2018, Volume 68, Issue 6, pp. 471 - 487
Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the... 
gastroenteropancreatic neuroendocrine tumor | treatment | carcinoid tumor | neuroendocrine tumor (NET) | NEOPLASIA TYPE-1 MEN1 | ENETS CONSENSUS GUIDELINES | ENDOCRINE TUMORS | AMERICAN JOINT COMMITTEE | OCTREOTIDE LAR | LIVER METASTASES | ONCOLOGY | CARCINOID-SYNDROME | ISLET-CELL TUMORS | CANCER STAGING CLASSIFICATION | ENDOTHELIAL GROWTH-FACTOR | Pancreatic Neoplasms - epidemiology | Pancreatic Neoplasms - diagnosis | Pancreatic Neoplasms - etiology | Humans | Antineoplastic Agents - therapeutic use | Neuroendocrine Tumors - diagnosis | Neuroendocrine Tumors - epidemiology | Incidence | Patient Selection | Stomach Neoplasms - epidemiology | Octreotide - administration & dosage | Intestinal Neoplasms - diagnosis | Stomach Neoplasms - etiology | Medical Oncology - methods | Stomach Neoplasms - diagnosis | Octreotide - analogs & derivatives | Biomarkers, Tumor - analysis | Stomach Neoplasms - therapy | Intestinal Neoplasms - etiology | Treatment Outcome | Intestinal Neoplasms - epidemiology | Cytoreduction Surgical Procedures - methods | Randomized Controlled Trials as Topic | Intestinal Neoplasms - therapy | Medical Oncology - standards | Neuroendocrine Tumors - therapy | Neuroendocrine Tumors - etiology | Organometallic Compounds - administration & dosage | Pancreatic Neoplasms - therapy | Practice Guidelines as Topic | Medical treatment | Hydroxylase | Liver | Tryptophan | Diarrhea | Hormones | Patients | Neuroendocrine system | Metastases | Tryptophan hydroxylase | Chemotherapy | Nets | Algorithms | Surgery | Biomarkers | Antitumor activity | Somatostatin | Temozolomide | Pancreas | Tumors | Neuroendocrine tumors
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2015, Volume 26, Issue 9, pp. 1987 - 1993
Journal Article
Virchows Archiv, ISSN 0945-6317, 10/2006, Volume 449, Issue 4, pp. 395 - 401
Journal Article
Journal Article
Neuroendocrinology, ISSN 0028-3835, 2004, Volume 80, Issue 6, pp. 394 - 424
Journal Article